Related Experiment Video
Updated: Mar 26, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Antimicrobial Properties of a Potential Probiotic Lactobacillus from Thai Newborn Feces
Insights
A novel Lactobacillus reuteri strain, MSMC64-1, produces reuterin and shows strong antimicrobial activity against pathogens like Salmonella typhi and MRSA. This probiotic isolate demonstrates potential for preventing and treating enteric infections.
Area of Science:
- Microbiology
- Probiotics
- Gastroenterology
Background:
- Probiotics, particularly Lactobacillus species, are increasingly utilized for managing infectious and antibiotic-associated diarrhea.
- Lactobacillus strains are known for their ability to colonize the infant gastrointestinal tract.
Purpose of the Study:
- To identify antimicrobial substances and assess antimicrobial activity in 200 Lactobacillus isolates from healthy Thai newborns.
- To characterize a specific Lactobacillus strain for its probiotic potential.
Main Methods:
- Reuterin production was quantified using spot overlay and colorimetric assays.
- Antimicrobial activity was evaluated against pathogenic bacteria via well diffusion and agar methods.
- Strain identification was performed using 16S ribosomal DNA sequencing.
Main Results:
- Lactobacillus strain MSMC64-1 produced reuterin, exhibiting potent antimicrobial activity against seven pathogenic strains, notably Salmonella typhi and methicillin-resistant Staphylococcus aureus (MRSA).
- The strain displayed strong inhibition against MRSA, Vibrio parahaemolyticus, and Shigella dysenteriae, with moderate to weak activity against Vibrio cholerae and Helicobacter pylori.
- MSMC64-1 demonstrated acid resistance (pH 2-4) and tolerance to bile concentrations up to 4%, and was identified as Lactobacillus reuteri.
Conclusions:
- The identified Lactobacillus reuteri strain MSMC64-1 possesses significant antimicrobial properties.
- This strain shows promise as a potential probiotic agent for the prevention and treatment of enteric infections.
Background:
Probiotics are increasingly used to treat infectious diarrhea and antibiotic-associated diarrhea. Many probiotic bacteria are classified in general such as Lactobacillus and are able to colonize the gastrointestinal tracts of infants.
Objective:
This study was performed to detect antimicrobial substances and activity in 200 Lactobacillus isolates obtained from healthy Thai newborn feces.
Material And Method:
Reuterin production was detected by the spot overlay technique and colorimetric assay. Antimicrobial activity was tested by using a well diffusion, agar method.
Results:
Lactobacillus strain MSMC64-1 produced reuterin and demonstrated potent antimicrobial activity against seven pathogenic indicator strains with very strong inhibitory activities against Salmonella typhi DMST 5784 and methicillin resistant Staphylococcus aureus (MRSA) DMST 20651. There was strong inhibitory activity against methicillin resistant Staphylococcus aureus (MRSA) DMST20654, Vibrio parahaemolyticus DMST 5665 and Shigella dysenteriae DMST 15111. There was moderate to weak inhibitory activities against Vibrio cholerae DMST 2873 and Helicobacter pylori (H40). The Lactobacillus strain MSMC 64-1 showed resistance to acidic pH (pH 2, 3, 4) and tolerance to 1%, 2%, 3%, and 4% bile concentrations. Sequencing of the 16S ribosomal DNA identified the candidate's strain as Lactobacillus reuteri with 98% sequence homology.
Conclusion:
The active isolate could potentially be used as a probiotic to prevent and treat enteric infections.
Related Concept Videos
Probiotics
Development of Human Microbiota
Development of the Oral Microbiota
Bacterial Phylum Firmicutes
Clinical Significance of Antibiotic Resistance
Microbes in the Production of Fermented Foods

